• Home
  • Search Results

Search Results

Open
Young Adult (18-34)
340 studies match your search
Open

A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy

Are you premenopausal and have been diagnosed with ER-positive, HER2-negative breast cancer and had surgery for your breast cancer? If so, you may be able to take part in a research study evaluating the addition of chemotherapy given after breast surgery with ovarian suppression and endocrine therapy versus ovarian suppression and endocrine therapy alone.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Cancer Family History in Black Families

The survey and its findings will help us understand attitudes around cancer family history and genetic testing among Black people. This information will be used to develop an educational curriculum to strive towards health equity for Black people diagnosed with or at higher risk of cancer and get Black people the best cancer care.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Brain and Other Nervous System, Breast, and 18 more)
  • Healthy Volunteer or General Population
  • Minority Health
Visit Location
100% Remote (online, phone, text)
Open

THC Vaping Study

Do you use a THC vaping device? Help us learn more about what it does to your lungs. Compensation will be provided.

Age & Gender
  • 21 years ~ 40 years
  • Male, Female, Gender Inclusive
Study Interest
  • Lungs and Breathing
Open

Drug-Free Treatment for Anxiety

Do you currently experience anxiety? Are you interested in trying a medication-free approach to treatment? If you are between 18 and 21 years old, you may be able to take part in a study to learn more about non-invasive brain stimulation, which has previously been shown to be effective in reducing anxiety symptoms in people 22 years and older.

Age & Gender
  • 18 years ~ 21 years
  • Male, Female, Gender Inclusive
Study Interest
  • Mental and Emotional Health
Open

Friendship Pathways Study

Do you ever notice that you feel more energized or alert when meeting new people and forming first impressions? Other times, a first meeting will rub you the wrong way and you may feel less attentive. If you've experienced one or both of these, you may wonder: What makes a good first impression? How do you know you want to become friends with someone? What information do we pay attention to when interacting with someone for the first time? Good questions! Neuroscience and psychology researchers wonder about the same things. Here at the Social Neuroscience and Health lab, we study how the brain and the immune system work together to influence our behaviors and experiences. The Friendship Pathways Study is a research project aiming to answer questions about how the brain and immune system communicate when meeting new people and forming friendships.

Age & Gender
  • 18 years ~ 30 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
  • Opinions and Perceptions
  • UNC or UNC Health employees
  • and 3 more
Open

SPECT-CT Guided Elective Contralateral Neck Treatment for Pts With Lateralized Oropharyngeal Cancer

Have you been diagnosed with Lateralized Oropharyngeal Cancer . If so, you may be able to take part in a research study looking at the safety by using a special imaging study called lymph node mapping (lymphatic mapping) Single Photon Emission Computed Tomography (SPECT-CT) compared to the usual treatment when radiotherapy is given .

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Head and Neck)
Open

Reduced Dose of Cyclophosphamide to Prevent Graft versus Host Disease after Stem Cell Transplant

Do you have AML, ALL, or MDS, and are preparing for a stem cell transplant from an unrelated donor? If so, you might be able to take part in a study to will see if a reduced dose of a drug called cyclophosphamide will still reduce your chances of developing Graft versus Host disease, but also lower your chances of side effects from the drug.

Age & Gender
  • 18 years ~ 65 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Leukemia, Lymphoma)
  • Transplant
Open

EFFEKTOR Study for Kidney Transplant Recipents

The study treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works by blocking a certain hormone called aldosterone that causes injury and inflammation in the heart and kidney which is known to play a role in CKD. In this study, the researchers want to learn if finerenone works the same way in kidney transplant recipients. Some subjects will receive the study drug and some will receive a placebo.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Kidneys and Liver
Open

Phase I Study of CAR-T Cells Targeting the B7-H3 Antigen in Patients with Refractory Pancreatic Ductal Adenocarcinoma (PDAC)

Do you have pancreatic ductal adenocarcinoma that has come back after receiving standard therapy? If so, you may be able to participate in this gene therapy research study to learn more about using you own modified immune cells as possible treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Pancreatic)
Open

CAR-T Cells in the Treatment of Patients with B Cell Malignancies

Have you been diagnosed with a B cell disease that has returned after your previous treatment or is not responding to your current treatment? If so, you might be able to take part in a study to see if a new treatment is safe and can help treat people with B-cell diseases.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research